In contrast, in colorectal cancer (CRC), we have reported Spry2 upregulation in high-grade tumors and at the invasion front of low-grade tumors [6], where the levels of Spry2 RNA and protein are higher in colon adenocarcinomas than in the adjacent normal mucosa [7]. This evidence concerns the gene SPRY2 and colorectal cancer.